AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30015676 — intervention group
Group type: COMPARATOR
Intervention: 21-day initiation regimen (15-mg daily dose of oral aripiprazole for 21 days)
Number of subjects: 161
Study 30015676 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day initiation regimen
Number of subjects: 161
Study 30015676 — intervention group
Group type: COMPARATOR
Intervention: 21-day initiation regimen
Number of subjects: 161
Study 26728002 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated and Reinforced Oral Health Education (RR-OHE)
Number of subjects: 935
Study 26728002 — intervention group
Group type: COMPARATOR
Intervention: One-time Oral Health Education (OHE) by dentist and peer-leaders
Number of subjects: 935
Study 26728002 — intervention group
Group type: COMPARATOR
Intervention: One-time Oral Health Education (OHE) by teachers
Number of subjects: 935
Study 26728002 — intervention group
Group type: COMPARATOR
Intervention: One-time OHE for all groups
Number of subjects: 935
Study 26728002 — intervention group
Group type: EXPERIMENTAL
Intervention: RR-OHE after 6 months
Number of subjects: 935
Study 26728002 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month evaluation of RR-OHE
Number of subjects: 935
Study 24992083 — intervention group
Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 80
Study 24992083 — intervention group
Group type: COMPARATOR
Intervention: Pramipexole or Ropinirole
Number of subjects: 80
Study 22523038 — intervention group
Group type: EXPERIMENTAL
Intervention: Kurzweil 3000 (K‐3000)
Number of subjects: 29
Study 22523038 — intervention group
Group type: COMPARATOR
Intervention: Control group (using pen and paper)
Number of subjects: 29
Study 19580131 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil perfusion at 1 microg x kg(‐1) x min(‐1) until intubation
Number of subjects: 54
Study 19580131 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl bolus dose of 2 microg x kg(‐1)
Number of subjects: 54
Study 17592713 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy at 45 degrees F
Number of subjects: 64
Study 17592713 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy at 75 degrees F
Number of subjects: 64
Study 16254088 — intervention group
Group type: EXPERIMENTAL
Intervention: Egalitarian group structure (democratic decision-making procedures)
Number of subjects: 0
Study 16254088 — intervention group
Group type: COMPARATOR
Intervention: Hierarchical group structure (authoritarian decision-making procedures)
Number of subjects: 0
Study 11888261 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on studies with new AEDs for bipolar disorder
Number of subjects: 0
Study 11888261 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials in epilepsy
Number of subjects: 0
Study 10331996 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist health visitor intervention
Number of subjects: 83
Study 10331996 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional care)
Number of subjects: 83
Study 10331996 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist health visitor intervention (children < 12 months)
Number of subjects: 83
Study 10331996 — intervention group
Group type: COMPARATOR
Intervention: Control (children < 12 months)
Number of subjects: 83
Study 10331996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study 10331996 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 7795095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 15 mg/kg daily for 3 days
Number of subjects: 438
Study 7795095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 10 mg/kg daily for 5 days
Number of subjects: 438
Study 7795095 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 438
Study 2219338 — intervention group
Group type: EXPERIMENTAL
Intervention: UW solution
Number of subjects: 0
Study 348379 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal, 250 mg twice daily
Number of subjects: 12
Study 348379 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA), 750 mg 4 times daily
Number of subjects: 12
Study 348379 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA), 600 mg 4 times daily
Number of subjects: 12
Study 348379 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 12
Study 348379 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) with alcohol
Number of subjects: 12
Study 30633363 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemically confirmed smoking cessation (quitters)
Number of subjects: 0
Study 30633363 — intervention group
Group type: COMPARATOR
Intervention: Continuing smokers (control)
Number of subjects: 0
Study 27752993 — intervention group
Group type: EXPERIMENTAL
Intervention: BEAT Cancer intervention
Number of subjects: 222
Study 27752993 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study 25844638 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-active condition (visuospatial WM, inhibition, cognitive-flexibility training)
Number of subjects: 89
Study 25844638 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially-active condition (inhibition and cognitive-flexibility training, WM training in placebo-mode)
Number of subjects: 89
Study 25844638 — intervention group
Group type: COMPARATOR
Intervention: Full placebo condition
Number of subjects: 89
Study 23963035 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-polyethylene bearings
Number of subjects: 92
Study 23963035 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal bearings
Number of subjects: 92
Study 21291959 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS with hand movements
Number of subjects: 12
Study 21291959 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with hand movements
Number of subjects: 12
Study 19188412 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitremer Tri-Cure Glass Ionomer System (3M ESPE Dental Products)
Number of subjects: 48
Study 19188412 — intervention group
Group type: EXPERIMENTAL
Intervention: Freedom (SDI)
Number of subjects: 48
Study 19188412 — intervention group
Group type: EXPERIMENTAL
Intervention: TPH Spectrum (Dentsply)
Number of subjects: 48
Study 17311843 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate/salmeterol combination treatment
Number of subjects: 911
Study 17311843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 911
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: AVF thrombosis
Number of subjects: 52
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline vascular access blood flow rate <700 ml/min
Number of subjects: 52
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: AVFs with baseline blood flow rates >700 ml/min
Number of subjects: 52
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: AVFs with baseline blood flow rates <700 ml/min
Number of subjects: 52
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 year cumulative actuarial survival
Number of subjects: 52
Study 14993512 — intervention group
Group type: EXPERIMENTAL
Intervention: AVFs remaining patent at the end of 4 years
Number of subjects: 52
Study 12585145 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling at Yang MP (Hegu, Quchi, Zusanli, Shangjuxu)
Number of subjects: 30
Study 12585145 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling at Yin MP (Neiguan, Chize, Sanyinjiao, Yinlingquan)
Number of subjects: 30
Study 9719081 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intensity
Number of subjects: 1550
Study 9719081 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose intensity
Number of subjects: 1550
Study 9719081 — intervention group
Group type: COMPARATOR
Intervention: Low-dose intensity
Number of subjects: 1550
Study 7715258 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous perfusion of NTG at 2 mg/h (Group A)
Number of subjects: 40
Study 7715258 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous perfusion of NTG at 4 mg/h (Group B)
Number of subjects: 40
Study 7715258 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subgroup A1 and B1)
Number of subjects: 40
Study 2516609 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO 50 U/kg
Number of subjects: 24
Study 2516609 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO 100 U/kg
Number of subjects: 24
Study 2516609 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO 150 U/kg
Number of subjects: 24
Study 2516609 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO maintenance phase
Number of subjects: 24
Study 2516609 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO
Number of subjects: 24
Study 144509 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumon Gel (etofenamate)
Number of subjects: 760
Study 144509 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 760
Study 144509 — intervention group
Group type: COMPARATOR
Intervention: Ointment I (2-hydroxyethyl salicylate and p-menthan-3-ol)
Number of subjects: 760
Study 144509 — intervention group
Group type: COMPARATOR
Intervention: Ointment II (3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidine)
Number of subjects: 760
Study 31734638 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body MRI including DWI/T2-weighted fused images
Number of subjects: 21
Study 31734638 — intervention group
Group type: COMPARATOR
Intervention: Whole-body MRI without fused images
Number of subjects: 21
Study 28124585 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (400 mg daily)
Number of subjects: 25
Study 28124585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 25937055 — intervention group
Group type: EXPERIMENTAL
Intervention: MgCl2 5% solution (30 mL, equivalent to 382 mg of magnesium)
Number of subjects: 116
Study 25937055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 23710976 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate or dexamphetamine (titrated doses)
Number of subjects: 42
Study 23710976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 22009030 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted treatment (arm A)
Number of subjects: 120
Study 22009030 — intervention group
Group type: COMPARATOR
Intervention: 2-week additional period of rest between FEC and docetaxel (arm B)
Number of subjects: 120
Study 19339674 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpdent silane and Unite bonding adhesive with 9.6% HF acid (Group 1)
Number of subjects: 80
Study 19339674 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliance silane and Unite bonding adhesive with 9.6% HF acid (Group 2)
Number of subjects: 80
Study 19339674 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpdent silane and Unite bonding adhesive with 5% HF acid (Group 3)
Number of subjects: 80
Study 19339674 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliance silane and Unite bonding adhesive with 5% HF acid (Group 4)
Number of subjects: 80
Study 16780258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebstein anomaly patients
Number of subjects: 56
Study 16780258 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD II patients
Number of subjects: 56
Study 15515752 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone scintigraphy with technetium‐99m‐hydroxy‐methylene‐diphosphonate (99mTc‐HMDP)
Number of subjects: 28
Study 11084783 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with autonomic neuropathy
Number of subjects: 50
Study 11084783 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients without autonomic neuropathy
Number of subjects: 50
Study 11084783 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study 8976637 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone propionate 50 mg intramuscularly every two weeks for one year
Number of subjects: 107
Study 8976637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 8976637 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone propionate
Number of subjects: 107
Study 2022477 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural interleukin‐2 (nIL‐2) 200 U
Number of subjects: 20
Study 2022477 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural interleukin‐2 (nIL‐2) 1,000 U
Number of subjects: 20
Study 2022477 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural interleukin‐2 (nIL‐2) 5,000 U
Number of subjects: 20
Study 7137536 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide 200 microgram per day
Number of subjects: 34
Study 7137536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30808612 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum (active) 2-mA tDCS
Number of subjects: 25
Study 30808612 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 25
Study 30808612 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum tDCS
Number of subjects: 25
Study 28733159 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder training video (BTV)
Number of subjects: 150
Study 28733159 — intervention group
Group type: COMPARATOR
Intervention: Standard urotherapy (SU)
Number of subjects: 150
Study 25287075 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced observers (7 members of the IST-3 expert image reading panel)
Number of subjects: 15
Study 25287075 — intervention group
Group type: COMPARATOR
Intervention: Radiology trainees (<2 years experience)
Number of subjects: 15
Study 25287075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer agreement among experts
Number of subjects: 15
Study 25437223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (500 mg)
Number of subjects: 0
Study 25437223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22838957 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pamphlet about genetic testing
Number of subjects: 140
Study 22838957 — intervention group
Group type: COMPARATOR
Intervention: Genetic counseling appointment at a family cancer center
Number of subjects: 140
Study 20436978 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg acetaminophen rectally
Number of subjects: 60
Study 20436978 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/kg acetaminophen orally
Number of subjects: 60
Study 17673105 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple baseline design
Number of subjects: 0
Study 17673105 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trial (RCT)
Number of subjects: 0
Study 16165255 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 16
Study 16165255 — intervention group
Group type: COMPARATOR
Intervention: Semi-recumbent position
Number of subjects: 16
Study 16165255 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position in non-refluxers
Number of subjects: 16
Study 16165255 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position in refluxers
Number of subjects: 16
Study 11900816 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone treatment (200 mg dose)
Number of subjects: 5
Study 11900816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 10086963 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardiac defibrillator (ICD)
Number of subjects: 900
Study 10086963 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic therapy (Control)
Number of subjects: 900
Study 7552790 — intervention group
Group type: EXPERIMENTAL
Intervention: Management and prevention of vascular catheter related infections
Number of subjects: 0
Study 2688071 — intervention group
Group type: COMPARATOR
Intervention: trimethoprim‐sulfamethoxazole (TMP‐SMX)
Number of subjects: 343
Study 2688071 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin (NF)
Number of subjects: 343
Study 5389 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg fluoride - 42 mg sucrose tablets
Number of subjects: 0
Study 5389 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free, sucrose-containing placebo tablets
Number of subjects: 0
Study 31594690 — intervention group
Group type: EXPERIMENTAL
Intervention: GLPG2737 (75mg)
Number of subjects: 22
Study 31594690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30537153 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management programme plus usual care
Number of subjects: 135
Study 30537153 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 135
Study 28456108 — intervention group
Group type: EXPERIMENTAL
Intervention: PDQ‐11 (Personal Diabetes Questionnaire scale)
Number of subjects: 411
Study 28456108 — intervention group
Group type: EXPERIMENTAL
Intervention: PDQ‐11 subscales
Number of subjects: 411
Study 23293007 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAYgrounds programme (intervention group)
Number of subjects: 1500
Study 23293007 — intervention group
Group type: COMPARATOR
Intervention: Control group (light PA)
Number of subjects: 1500
Study 22706585 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (CPG)
Number of subjects: 20
Study 22706585 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (RBRZ)
Number of subjects: 20
Study 22706585 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of Clopidogrel and Rabeprazole
Number of subjects: 20
Study 22706585 — intervention group
Group type: EXPERIMENTAL
Intervention: ADP-induced platelet aggregation
Number of subjects: 20
Study 21928866 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-focus alcohol risk-reduction intervention
Number of subjects: 154
Study 21928866 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-focus HIV risk-reduction intervention
Number of subjects: 154
Study 21928866 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 154
Study 19935143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation with relaxation therapy (CPRT)
Number of subjects: 81
Study 19935143 — intervention group
Group type: COMPARATOR
Intervention: Cardiac rehabilitation alone (CPA)
Number of subjects: 81
Study 19935143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac-related hospital admissions
Number of subjects: 81
Study 20970896 — intervention group
Group type: EXPERIMENTAL
Intervention: diet/probiotics
Number of subjects: 256
Study 20970896 — intervention group
Group type: EXPERIMENTAL
Intervention: diet/placebo
Number of subjects: 256
Study 20970896 — intervention group
Group type: COMPARATOR
Intervention: control/placebo
Number of subjects: 256
Study 15763433 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (75 mg daily)
Number of subjects: 639
Study 12215748 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sublingual isosorbide dinitrate (2.5 mg) during HUTT
Number of subjects: 43
Study 12215748 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol infusion (1 to 3 µg/min) during HUTT
Number of subjects: 43
Study 12215748 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive period of HUTT
Number of subjects: 43
Study 9694469 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection rate of 2 ml/sec
Number of subjects: 100
Study 9694469 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection rate of 3 ml/sec
Number of subjects: 100
Study 9694469 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection rate of 4 ml/sec
Number of subjects: 100
Study 9694469 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection rate of 5 ml/sec
Number of subjects: 100
Study 7521377 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM anti‐HCV
Number of subjects: 40
Study 7521377 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV RNA
Number of subjects: 40
Study 2918332 — intervention group
Group type: EXPERIMENTAL
Intervention: Excisional biopsy plus radiation
Number of subjects: 191
Study 2918332 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conservation surgery
Number of subjects: 191
Study 2918332 — intervention group
Group type: COMPARATOR
Intervention: Control group (Mastectomy)
Number of subjects: 191
Study 4940158 — intervention group
Group type: EXPERIMENTAL
Intervention: D. pteronyssinus extract
Number of subjects: 11
Study 4940158 — intervention group
Group type: COMPARATOR
Intervention: Human skin scales extract
Number of subjects: 11
Study 11452241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (daily and weekly dosing)
Number of subjects: 60
Study 11452241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone with rifabutin
Number of subjects: 60
Study 11452241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone in black children
Number of subjects: 60
Study 11452241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone in children younger than 2 years old
Number of subjects: 60
Study 11452241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone exposure parameters
Number of subjects: 60
Study 30919036 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g myo-Inositol combined with 400 mg folic acid
Number of subjects: 50
Study 30919036 — intervention group
Group type: COMPARATOR
Intervention: 400 mg folic acid
Number of subjects: 50
Study 29546297 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-rich meals
Number of subjects: 32
Study 29546297 — intervention group
Group type: COMPARATOR
Intervention: SFA-rich meals
Number of subjects: 32
Study 29546297 — intervention group
Group type: EXPERIMENTAL
Intervention: n-6 PUFA-rich meals
Number of subjects: 32
Study 27098499 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose (2 mL of 88% sucrose solution)
Number of subjects: 87
Study 27098499 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL of placebo solution)
Number of subjects: 87
Study 24651746 — intervention group
Group type: EXPERIMENTAL
Intervention: Submillisievert IMR (iterative model reconstruction)
Number of subjects: 10
Study 24651746 — intervention group
Group type: EXPERIMENTAL
Intervention: Submillisievert iDose
Number of subjects: 10
Study 24651746 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose FBP (filtered back projection)
Number of subjects: 10
Study 24651746 — intervention group
Group type: EXPERIMENTAL
Intervention: Submillisievert IMR
Number of subjects: 10
Study 21958117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial allergen challenge with HDM
Number of subjects: 27